Literature DB >> 26212265

ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications.

Rui Zhang1,2,3,4,5, Jiali Wang1,2,3,4,5, Mengyang Xue1,2,3,4,5, Feng Xu1,2,3,4,5, Yuguo Chen1,2,3,4,5.   

Abstract

BACKGROUND: The human aldehyde dehydrogenase 2 (ALDH2) is the most effective enzyme in the detoxification of alcohol metabolite acetaldehyde. The ALDH2*2 mutation is caused by a single nucleotide substitution which results in a nearly inactive form of ALDH2 enzyme. The ALDH2 genotype has been used as a surrogate of alcohol to get causal inferences of alcohol in related diseases implementing Mendelian randomization approach. In addition, ALDH2 enzyme has significant effect on different diseases, indicating the potential therapeutic value of ALDH2 regulators including both activators like Alda-1 and inhibitors such as daidzin and daidzein.
OBJECTIVE: In this review, we aim to systematically discuss the implications of ALDH2 genotype and ALDH2 enzyme regulators, highlighting their epidemiological and clinical importance, respectively.
CONCLUSION: ALDH2 polymorphism is shown to be a genetic instrument for alcohol use in Mendelian randomization analysis. ALDH2 regulators exhibit potential therapeutic value as the important roles of ALDH2 in various diseases. Both the genetic polymorphism and enzyme activity regulation of ALDH2 are of great importance to their epidemiologic and clinical applications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  ALDH2 activator; ALDH2 inhibitor; Aldehyde dehydrogenase 2 (ALDH2); Mendelianzzm321990randomization; genetic polymorphism; observational epidemiology

Mesh:

Substances:

Year:  2017        PMID: 26212265     DOI: 10.2174/1389450116666150727115118

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  6 in total

Review 1.  ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective.

Authors:  Jeffrey S Chang; Jenn-Ren Hsiao; Che-Hong Chen
Journal:  J Biomed Sci       Date:  2017-03-03       Impact factor: 8.410

2.  Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention.

Authors:  Lizhi Lv; Weijie Ye; Peiyuan Song; Yubin Chen; Jing Yang; Congmin Zhang; Xiaoping Chen; Fanyan Luo
Journal:  BMC Cardiovasc Disord       Date:  2019-07-25       Impact factor: 2.298

3.  Consumption of Alcoholic Beverages and the Prevalence of Metabolic Syndrome and Its Components.

Authors:  Edyta Suliga; Dorota Kozieł; Elzbieta Ciesla; Dorota Rebak; Martyna Głuszek-Osuch; Stanisław Głuszek
Journal:  Nutrients       Date:  2019-11-14       Impact factor: 5.717

4.  Alcohol consumption is associated with glaucoma severity regardless of ALDH2 polymorphism.

Authors:  Young Soo Han; Yong Woo Kim; Yu Jeong Kim; Ki Ho Park; Jin Wook Jeoung
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

5.  Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.

Authors:  Suchi Chang; Jian Wu; Jifu Jin; Huairui Shi; Rifeng Gao; Xiao Li; Daile Jia; Xiaolei Sun; Tiantong Ou; Ji'e Yang; Aijun Sun; Junbo Ge
Journal:  Oxid Med Cell Longev       Date:  2022-06-20       Impact factor: 7.310

6.  Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.

Authors:  Tonghui Xu; Jialin Guo; Maozeng Wei; Jiali Wang; Kehui Yang; Chang Pan; Jiaojiao Pang; Li Xue; Qiuhuan Yuan; Mengyang Xue; Jian Zhang; Wentao Sang; Tangxing Jiang; Yuguo Chen; Feng Xu
Journal:  JCI Insight       Date:  2021-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.